TY - JOUR
T1 - Successful program for recovery of dropouts to a clinical trial
AU - Probstfield, Jeffrey L.
AU - Russell, Michael L.
AU - Henske, Janice C.
AU - Reardon, Ronald J.
AU - Insull, William
N1 - Funding Information:
From the Baylor-Methodist Lipid Research Clinic, the Department of Medicine, Baylor College of Medicine, Houston, Texas. This work was supported in part by Contract HVI-2156-L (LRC) from the National Heart, Lung, and Blood Institute. Requests for reprints should be addressed to Dr. Basil M. Rifkind, Lipid Metabolism-Atherogenesis Branch, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, Federal Building, Room 401, Bethesda, Maryland 20892. Manuscript accepted April 2, 1985.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1986/5
Y1 - 1986/5
N2 - This is a report of a successful program to return dropout participants to active participation at a single clinic of a multicenter long-term clinical trial, the Coronary Primary Prevention Trial of the Lipid Research Clinics Program. The specific objectives were to re-engage dropouts into active participation and to have them resume study medication. Thirty-six men had been absent from the Baylor-Methodist Clinic for 10 months to over four years. The program focused on resolving the presenting problems: psychosocial, somatic, and drug adherence. It was based on six general principles with corresponding goals and employed 13 activities and procedures in a specific operational sequence for reinstitution of the Coronary Primary Prevention Trial protocol. Counseling techniques were used to improve protocol adherence. The recovery program was monitored bi-weekly by computer. The dropout group did not appear to exhibit any biases and approximated the remainder of the Baylor-Methodist cohort demographically. At six months into the recovery program, 90 percent of the dropouts had been recovered. Seventy percent of the recovered participants re-established medication-taking behavior. The mean rate of adherence to medication for all of the recovered group was 35 percent of the prescribed dose, 8 g per day. Review of the data for the cholesterol differential between the two treatment groups demonstrated a favorable effect of the reinstitution of the study medication. The program's methods are applicable to clinical practice.
AB - This is a report of a successful program to return dropout participants to active participation at a single clinic of a multicenter long-term clinical trial, the Coronary Primary Prevention Trial of the Lipid Research Clinics Program. The specific objectives were to re-engage dropouts into active participation and to have them resume study medication. Thirty-six men had been absent from the Baylor-Methodist Clinic for 10 months to over four years. The program focused on resolving the presenting problems: psychosocial, somatic, and drug adherence. It was based on six general principles with corresponding goals and employed 13 activities and procedures in a specific operational sequence for reinstitution of the Coronary Primary Prevention Trial protocol. Counseling techniques were used to improve protocol adherence. The recovery program was monitored bi-weekly by computer. The dropout group did not appear to exhibit any biases and approximated the remainder of the Baylor-Methodist cohort demographically. At six months into the recovery program, 90 percent of the dropouts had been recovered. Seventy percent of the recovered participants re-established medication-taking behavior. The mean rate of adherence to medication for all of the recovered group was 35 percent of the prescribed dose, 8 g per day. Review of the data for the cholesterol differential between the two treatment groups demonstrated a favorable effect of the reinstitution of the study medication. The program's methods are applicable to clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=0022517465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022517465&partnerID=8YFLogxK
U2 - 10.1016/0002-9343(86)90615-7
DO - 10.1016/0002-9343(86)90615-7
M3 - Article
C2 - 3706364
AN - SCOPUS:0022517465
SN - 0002-9343
VL - 80
SP - 777
EP - 784
JO - The American journal of medicine
JF - The American journal of medicine
IS - 5
ER -